Back to Community
Question
Key differences between SGLT2 inhibitors and GLP-1 RAs in heart failure patients?
Looking for clinical consensus and preceptor experiences regarding Key differences between SGLT2 inhibitors and GLP-1 RAs in heart failure patients?. Please share your institutional protocols and guidelines.
1 Comments
1Great question! According to clinical practice guidelines, baseline TDM and eGFR monitoring should be performed prior to dose titration.